Antibiotic-induced Toxic Epidermal Necrolysis - A Case Report.

Acta Dermatovenerol Croat

Višnja Nesek Adam, MD, Žerjavićeva 12, 10000 , Zagreb , Croatia;

Published: April 2017

Toxic epidermal necrolysis (TEN) is severe cutaneous hypersensitivity reaction characterized by necrosis of the epidermis and detachment of the epidermis and dermis that usually occurs as an idiosyncratic reaction to certain drugs. We report the case of a patient admitted to our Intensive Care Unit after an above-the-knee amputation who developed toxic epidermal necrolysis, possibly resulting from antibiotics therapy. Therapy included a combination of intravenous immunoglobulin with gentle early debridement of necrotic skin areas followed by wound coverage with a synthetic cover (Aquacel Ag®). This case report suggests that intensive wound management together with intravenous immunoglobulin might be beneficial in the treatment of patients with TEN.

Download full-text PDF

Source

Publication Analysis

Top Keywords

toxic epidermal
12
epidermal necrolysis
12
case report
8
intravenous immunoglobulin
8
antibiotic-induced toxic
4
necrolysis case
4
report toxic
4
necrolysis ten
4
ten severe
4
severe cutaneous
4

Similar Publications

Diquat Induces Cell Death and dopamine Neuron Loss via Reactive Oxygen Species Generation in .

Environ Sci Technol

January 2025

School of Tropical Agriculture and Forestry, Hainan University, Haikou 570228, China.

Diquat (DQ), a contact herbicide extensively utilized in both agricultural and nonagricultural domains, exhibits a high correlation with neuronal disorders. Nevertheless, the toxicity and underlying mechanisms associated with exposure to environmental concentrations of DQ remain ambiguous. Here, we report dose-dependent cellular neurotoxicity of DQ in .

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) have garnered significant attention as an innovative therapeutic strategy in cancer treatment. The mechanism of action for ADCs involves the targeted delivery of antibodies to specific receptors, followed by the release of cytotoxic payloads directly into tumor cells. In recent years, ADCs have made substantial progress in the treatment of breast cancer (BC), particularly demonstrating significant efficacy in the human epidermal growth factor receptor-2 (HER-2)-positive subgroup.

View Article and Find Full Text PDF

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patients with ≥1 echocardiogram post-osimertinib between 2007 and 2022 was performed.

View Article and Find Full Text PDF

This study explores the protective role of Atractylodin (ATN) on ultraviolet-B (UVB) radiation-exposed oxidative damage and photoaging responses in human epidermal keratinocytes (HaCaT). In vitro, experiments involved subjecting HaCaT cells to UVB radiation (50 mJ/cm) for a 24 h incubation period, leading to cell death, increased reactive oxygen species (ROS), and DNA damaged lesion (8-Oxo Gunosine). ATN treatment effectively mitigated cell toxicity, ROS generation, and 8-Oxo Gunosine in UVB-exposed HaCaT cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the harmful effects of the pesticide etoxazole on the plant Allium cepa (onion) and explores the protective role of Achillea millefolium (yarrow) extract against this toxicity.
  • The research showed that etoxazole exposure significantly reduced growth metrics (like rooting percentage and root length) and increased harmful cellular changes, including chromosomal abnormalities.
  • Molecular docking results indicated that etoxazole directly interacts with DNA and key proteins, while A. millefolium extract, rich in phenolic compounds, may mitigate some of the toxic effects caused by the pesticide.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!